A New York hospital group's PR firm sends out press releases urging reporters to quote its experts on embargoed studies by other researchers, Ivan Oransky writes on Embargo Watch. A clever way to help writers and get ink? Or too clever, since the journal publishing the studies did not consent? "Other hospitals, playing closer to the rules, might wish they had thought of this strategy before. But I wonder if this isn’t the scientific embargo version of insider trading."
February 12, 2013